VTGN
Vistagen Therapeutics Inc.
$3.94
+$0.19(+5.07%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$124.26M
Volume
231.63K
52W Range
$1.90 - $4.52
Target Price
$13.00
EPS Estimates Overview
| Current Quarter | $-0.51 | Next Quarter | $-0.32 |
| Current Year | $-1.56 | Next Year | $-1.71 |
| QoQ Growth | +37.3% | YoY Growth | -9.6% |
| 3Y EPS CAGR | +39.4% | Target Price | $13.00 |
| Consensus | Buy | Upside | +229.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $3.94 | +5.1% | 231.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vistagen Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW